20 results
8-K
EX-2.1
SPRY
ARS Pharmaceuticals Inc
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
are in substantial compliance with all applicable Laws pertaining to data privacy and data security of any personally identifiable information and sensitive … are in substantial compliance with all applicable Laws pertaining to data privacy and data security of Sensitive Data, except to the extent
DEFM14A
z95ag
6 Oct 22
Proxy related to merger
4:16pm
PRER14A
27c6m9z pj
16 Sep 22
Preliminary revised proxy
4:56pm
PREM14A
w0tcq5
11 Aug 22
Preliminary proxy related to merger
5:22pm
DEFA14A
dej0t nplmlg
21 Jul 22
Additional proxy soliciting materials
5:05pm
8-K
EX-2.1
s8tbb115ilkon4j
21 Jul 22
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
5:01pm
10-Q
wigulba1xeo9 e22
13 May 21
Quarterly report
4:21pm
10-K
fx4bkcdt90e
29 Mar 21
Annual report
4:13pm
424B4
198hto321hlj5 k3x
4 Dec 20
Prospectus supplement with pricing info
4:04pm
S-1/A
u24qglrz
30 Nov 20
IPO registration (amended)
6:06am
S-1
7z544q
10 Nov 20
IPO registration
4:46pm
DRS
3ld2cia
2 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next